Department of Ophthalmology, University Hospital Centre Sestre milosrdnice, Zagreb, Croatia.
Department of Pharmacology, University of Mostar School of Medicine, Mostar, Bosnia and Herzegovina.
Med Arch. 2021 Apr;75(2):144-148. doi: 10.5455/medarh.2021.75.144-148.
In the year 2020 we observe the world adapting to "new normal" due to the COVID-19 pandemic, ways of which include physical distancing, hand hygiene, and wearing a face mask. There is no conclusive evidence about ocular manifestations of the new coronavirus infection, but cases of conjunctivitis, keratitis, and episcleritis have been reported in infected individuals.
Determining if wearing a face mask during COVID-19 pandemic causes a new onset or deterioration of previously existing dry eye disease (DED).
A prospective cohort study included 203 participants, all using surgical facemasks daily due to new regulations during COVID-19 pandemic. Participants completed a survey, containing modified Ocular Surface Disease Index (OSDI) questionnaire. They were divided into groups according to: sex, age, duration of face mask-wear, and existence of prior DED history.
Our results indicate that women have a statistically higher OSDI score compared to men (14.4 (IQR = 2.4 - 41.7) vs. 5.0 (IQR = 0.0 - 24.4); = .004). Age did not significantly affect OSDI median values. Group that used masks from 3 to 6 hours/day demonstrated significantly higher OSDI scores compared to <3 hour/day group (15.3 (IQR = 8.3 - 47.7) vs. 8.3 (IQR = 0.0 - 35.1); = .001). OSDI score was significantly greater in participants with prior DED history compared to those without it (36.1 (IQR = 14.1 - 61.6) vs. 4.2 (IQR = 2.3 - 8.3); <.001). Participants with prior DED exhibited greater worsening of their disturbances during mask wearing period compared to the ones without previous DED (54.8% vs. 17.7%, Chi-Square 28.3 DF1; <.001), regardless of daily mask wear duration.
Our study confirmed the existence of mask-associated dry eye (MADE), most profoundly in females, subjects with a history of prior DED, and if wearing a face mask lasts longer than 3 hours per day. Ophthalmologists should advise their patients of the potential ocular surface health risks related to inadequately fitted facemasks.
在 2020 年,由于 COVID-19 大流行,世界正在适应“新常态”,其中包括保持身体距离、手部卫生和佩戴口罩。目前尚无关于新冠病毒感染眼部表现的确凿证据,但在感染人群中已报告有结膜炎、角膜炎和表层巩膜炎病例。
确定在 COVID-19 大流行期间佩戴口罩是否会导致新发或原有干眼症(DED)恶化。
一项前瞻性队列研究纳入了 203 名参与者,他们均因 COVID-19 大流行期间的新规定而每天佩戴外科口罩。参与者完成了一项包含改良眼表疾病指数(OSDI)问卷的调查。他们根据以下分组:性别、年龄、口罩佩戴时间和是否存在先前 DED 病史。
我们的结果表明,与男性相比,女性的 OSDI 评分明显更高(14.4(IQR=2.4-41.7)vs.5.0(IQR=0.0-24.4); =.004)。年龄对 OSDI 中位数无显著影响。每天戴口罩 3-6 小时的组与每天戴口罩<3 小时的组相比,OSDI 评分明显更高(15.3(IQR=8.3-47.7)vs.8.3(IQR=0.0-35.1); =.001)。有先前 DED 病史的参与者的 OSDI 评分明显高于无病史者(36.1(IQR=14.1-61.6)vs.4.2(IQR=2.3-8.3); <.001)。与无先前 DED 的参与者相比,有先前 DED 病史的参与者在佩戴口罩期间,其眼部不适的恶化程度更大(54.8% vs.17.7%,卡方 28.3 自由度 1; <.001),而与每天戴口罩的时间无关。
本研究证实了口罩相关干眼(MADE)的存在,在女性、有先前 DED 病史的患者以及每天佩戴口罩时间超过 3 小时的患者中更为明显。眼科医生应告知其患者佩戴不合适的口罩可能对眼表健康造成的潜在风险。